Advertisement

Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications

  • Klaus-Martin KreuselEmail author
  • Nikolaos Bechrakis
  • Juliane Riese
  • Lothar Krause
  • Joachim Wachtlin
  • Michael H. Foerster
Clinical Investigation

Abstract

Background

To determine the effectiveness and risk profile of combined ruthenium- (Ru)-106-brachytherapy and transpupillary thermotherapy (TTT) of the tumour apex for the treatment of large choroidal melanoma.

Methods

A consecutive series of 31 large choroidal melanoma treated by Ru-106-brachytherapy and adjuvant TTT was studied. TTT was performed 1 day prior to plaque removal and up to 3 times (mean: 1.8) during follow-up. Evaluation comprised tumour regression, treatment-related adverse events, necessity of additional treatment and visual results.

Results

Mean follow-up was 21.6±7.8 (10.8–38.3) months. Mean tumour thickness was 6.8±1.0 (5.0–8.9) mm prior to treatment. Mean residual tumour thickness at the end of follow-up was 2.5±1.0 mm. Relevant adverse treatment effects were exudative maculopathy or macula oedema (22.6%), vitreous haemorrhage (16.1%), optic neuropathy (16.1%) and retinal detachment (9.7%). One tumour recurrence occurred during follow-up, and was treated by enucleation.

Conclusions

The combination of Ru-106-brachytherapy with TTT allows for the treatment of large posterior choroidal melanoma. The rate of treatment-related adverse events appears to be acceptable.

Keywords

Choroidal melanoma Transpupillary thermotherapy Brachytherapy 

References

  1. 1.
    Bartlema YM, Oosterhuis JA, Journee-De Korver JG, Tjho-Heslinga RE, Keunen JE (2003) Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years’ experience. Br J Ophthalmol 87:1370–1373PubMedCrossRefGoogle Scholar
  2. 2.
    Bechrakis NE, Bornfeld N, Zoller I, Foerster MH (2001) Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas]. Ophthalmologe 98:736–742PubMedCrossRefGoogle Scholar
  3. 3.
    Bechrakis NE, Foerster MH (2006) Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin 46:95–107PubMedCrossRefGoogle Scholar
  4. 4.
    Bechrakis NE, Hocht S, Martus P, Kreusel KM, Heese J, Foerster MH (2004) Endoresection following proton beam irradiation of large uveal melanomas] Ophthalmologe 101:370–376PubMedCrossRefGoogle Scholar
  5. 5.
    Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S (2005) Ruthenium brachytherapy for uveal melanoma, 1979–2003: survival and functional outcomes in the Swedish population. Ophthalmology 112:834–840PubMedCrossRefGoogle Scholar
  6. 6.
    Bornfeld N, Talies S, Anastassiou G, Schilling H, Schuler A, Horstmann GA (2002) Endoscopic resection of malignant melanomas of the uvea after preoperative stereotactic single dose convergence irradiation with the Leksell gamma knife. Ophthalmologe 99:338–344PubMedCrossRefGoogle Scholar
  7. 7.
    Foerster MH, Bornfeld N, Wessing A, Schulz U, Schmitt G, Meyer-Schwickerath G (1984) Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases. Klin Monatsbl Augenheilkd 185:490–494PubMedCrossRefGoogle Scholar
  8. 8.
    Gragoudas ES, Seddon J, Goitein M, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Koehler A (1985) Current results of proton beam irradiation of uveal melanomas. Ophthalmology 92:284–291PubMedGoogle Scholar
  9. 9.
    Journee-de Korver JG, Oosterhuis JA, de Wolff-Rouendaal D, Kemme H (1997) Histopathological findings in human choroidal melanomas after transpupillary thermotherapy. Br J Ophthalmol 81:234–239PubMedCrossRefGoogle Scholar
  10. 10.
    Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM, de Wolff-Rouendaal D (1992) Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol 82:185–191PubMedCrossRefGoogle Scholar
  11. 11.
    Lommatzsch P, Vollmar R (1966) A new way in the conservative therapy of intraocular tumors by means of beta-irradiation (Ruthenium 106) with preservation of vision. Klin Monatsbl Augenheilkd 148:682–699PubMedGoogle Scholar
  12. 12.
    Lommatzsch PK, Werschnik C, Schuster E (2000) Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefe's Arch Clin Exp Ophthalmol 238:129–137CrossRefGoogle Scholar
  13. 13.
    Meyer-Schwickerath G (1980) Photocoagulation of choroidal melanomas. Doc Ophthalmol 50:57–61PubMedCrossRefGoogle Scholar
  14. 14.
    Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC (1995) Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 113:315–321PubMedGoogle Scholar
  15. 15.
    Oosterhuis JA, Journee-de Korver HG, Keunen JE (1998) Transpupillary thermotherapy: results in 50 patients with choroidal melanoma. Arch Ophthalmol 116:157–162PubMedGoogle Scholar
  16. 16.
    Robertson DM (2002) TTT as rescue treatment for choroidal melanoma not controlled with iodine-125 brachytherapy. Ocul Immunol Inflamm 10:247–252PubMedCrossRefGoogle Scholar
  17. 17.
    Seregard S, Landau I (2001) Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma. Acta Ophthalmol Scand 79:19–22PubMedCrossRefGoogle Scholar
  18. 18.
    Shields CL, Cater J, Shields JA, Chao A, Krema H, Materin M, Brady LW (2002) Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 120:933–940PubMedGoogle Scholar
  19. 19.
    Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J (2002) Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Ophthalmology 109:1838–1849PubMedCrossRefGoogle Scholar
  20. 20.
    Shields CL, Shields JA, Perez N, Singh AD, Cater J (2002) Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 109:225–234PubMedCrossRefGoogle Scholar
  21. 21.
    Singh AD, Topham A (2003) Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 110:956–961PubMedCrossRefGoogle Scholar
  22. 22.
    Stoffelns BM, Kutzner J, Jochem T (2002) Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid. Klin Monatsbl Augenheilkd 219:216–220PubMedCrossRefGoogle Scholar
  23. 23.
    Stoffelns BM, Kutzner J, Schopfer K, Frising M (2002) Prospective nonrandomised analysis of “sandwich therapy” for malignant melanoma of the choroid. Klin Monatsbl Augenheilkd 219:211–215PubMedCrossRefGoogle Scholar
  24. 24.
    Teikari JM, Raivio I (1985) Incidence of choroidal malignant melanoma in Finland in the years 1973–1980. Acta Ophthalmol (Copenh) 63:661–665CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Klaus-Martin Kreusel
    • 1
    Email author
  • Nikolaos Bechrakis
    • 2
  • Juliane Riese
    • 2
  • Lothar Krause
    • 2
  • Joachim Wachtlin
    • 2
  • Michael H. Foerster
    • 2
  1. 1.Augen-Zentrum, DRK-Kliniken WestendBerlinGermany
  2. 2.Universitätsaugenklinik und Poliklinik, Charité - Campus Benjamin FranklinBerlinGermany

Personalised recommendations